Rep. Gilbert Ray Cisneros, Jr. Sells Off Zoetis Inc. (NYSE:ZTS) Stock

Key Points

• Rep. Gilbert Ray Cisneros Jr. sold between $1,001 and $15,000 of Zoetis stock on July 17, according to a disclosure filed September 4.
• Zoetis reported quarterly EPS of $1.87, slightly above analyst expectations, while revenue of $2.47 billion fell short of estimates and declined 0.2% year over year.
• Analysts maintain a consensus “Hold” rating with an average price target of $107.43; Zoetis is priced at $75.70, and institutional investors own 92.8% of its shares.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Zoetis Inc. (NYSE:ZTS). In a filing disclosed on September 04th, the Representative disclosed that they had sold between $1,001 and $15,000 in Zoetis stock on July 17th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Mesabi Trust NYSE: MSB on 7/31/2026.
• Purchased $1,001 - $15,000 in shares of Praxis Precision Medicines NASDAQ: PRAX on 7/30/2026.
• Purchased $15,001 - $50,000 in shares of Alkermes NASDAQ: ALKS on 7/30/2026.
• Sold $15,001 - $50,000 in shares of Crinetics Pharmaceuticals NASDAQ: CRNX on 7/30/2026.
• Sold $100,001 - $250,000 in shares of Alibaba Group NYSE: BABA on 7/24/2026.
• Sold $1,001 - $15,000 in shares of Adobe NASDAQ: ADBE on 7/24/2026.
• Sold $1,001 - $15,000 in shares of Viavi Solutions NASDAQ: VIAV on 7/21/2026.
• Purchased $1,001 - $15,000 in shares of SailPoint NASDAQ: SAIL on 7/21/2026.
• Purchased $1,001 - $15,000 in shares of Glacier Bancorp NYSE: GBCI on 7/21/2026.
• Sold $1,001 - $15,000 in shares of FedEx NYSE: FDX on 7/21/2026.

Zoetis Stock Performance

ZTS opened at $75.70 on Tuesday. The business's 50 day moving average is $75.58 and its 200-day moving average is $93.26. The stock has a market cap of $31.28 billion, a PE ratio of 12.47, a price-to-earnings-growth ratio of 1.77 and a beta of 0.73. The company has a current ratio of 3.08, a quick ratio of 1.84 and a debt-to-equity ratio of 2.87. Zoetis Inc. has a twelve month low of $71.00 and a twelve month high of $155.15.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.02. The business had revenue of $2.47 billion during the quarter, compared to the consensus estimate of $2.50 billion. Zoetis had a return on equity of 74.89% and a net margin of 27.49%.The business's revenue was down .2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.76 earnings per share. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. On average, analysts predict that Zoetis Inc. will post 6.2 earnings per share for the current year.

Institutional Investors Weigh In On Zoetis

Several large investors have recently modified their holdings of the stock. California State Teachers Retirement System boosted its stake in shares of Zoetis by 6,680.3% during the 2nd quarter. California State Teachers Retirement System now owns 47,745,365 shares of the company's stock valued at $3,430,982,000 after buying an additional 47,041,186 shares during the period. J. Stern & Co. LLP increased its stake in shares of Zoetis by 12,431.2% in the fourth quarter. J. Stern & Co. LLP now owns 24,069,492 shares of the company's stock worth $3,028,423,000 after acquiring an additional 23,877,416 shares during the last quarter. Norges Bank acquired a new position in shares of Zoetis in the fourth quarter worth $734,425,000. Flossbach Von Storch SE purchased a new stake in shares of Zoetis during the second quarter worth $302,601,000. Finally, BlackRock Inc. raised its holdings in shares of Zoetis by 10.8% during the second quarter. BlackRock Inc. now owns 39,430,181 shares of the company's stock worth $2,833,453,000 after acquiring an additional 3,845,869 shares in the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ZTS has been the topic of several recent analyst reports. Cantor Fitzgerald set a $94.00 target price on Zoetis in a report on Tuesday, August 25th. Piper Sandler lowered their price target on Zoetis from $90.00 to $80.00 and set a "neutral" rating on the stock in a research report on Monday, August 10th. Barclays dropped their price objective on Zoetis from $136.00 to $85.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 1st. UBS Group cut their price objective on Zoetis from $85.00 to $80.00 and set a "neutral" rating for the company in a report on Friday, August 7th. Finally, TD Cowen decreased their target price on Zoetis from $104.00 to $94.00 and set a "buy" rating for the company in a research note on Tuesday, August 25th. Eight research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Zoetis presently has a consensus rating of "Hold" and a consensus price target of $107.43.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Zoetis Company Profile

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.